个人简介:Dr. Joe X Zhou, CEO of GenorBioPharma Co.Ltd.,Walvax Group. Dr. Joe Zhou is the CEO of Genor Biopharma Co. Ltd. Vice President and R&D Head of Walvax Group. He also is a visiting professor teaching Master’s Degree Program in International Pharmaceutical Engineering Management (IPEM)at Peking University, China. He is an invited vice-chair of Biopharmaceuticals Committee under China Pharmaceuticals Society, the Founder and first Chair of China Protein Drug Quality Alliance (CPDQA), the first Chair of Biological Drug Product and Process Committee of China ISPE, and the Chair of Amgen Aluminums Association (AAA) in China. Under his guidance, Genor Biopharma has 3 mAbbiosimilars in Phase 3 clinical studies and 2 novel mAb (including PD-1 antibody) in Phase 1 studies. This company filed 10 IND in total in past 9 years.
Previously, Dr. Zhou was Scientific Director at Amgen, Thousand Oaks, USA. His over 20-years’ experience of process development, multiple project management capacity in cGMP and non-GMP reproducible purification/production of protein/antibody therapeutics from FIH to CPD with depth knowledge of CHO clone selection, cell culture optimization, real time analytical assays, formulation and product specification for drug substances and drug products made Dr. Zhou many times as Project Process Team Leader/Project Team Leader/Cross Functional Core Investigation Teams Leaders at Amgen in the past.